Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Configuration of cell facter IL-24 eucargon expression carrier and application

A technology of eukaryotic expression vectors and cytokines, which is applied in the fields of molecular immunology and tumor immunology, can solve the problems of biological safety, liver cancer, and small intestine cancer, which have not been reported in the treatment effect, and achieve simple treatment methods and reliable experimental basis Effect

Inactive Publication Date: 2005-05-25
WUHAN UNIV
View PDF0 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0017] 4.2 There may be an anti-tumor mechanism
[0021] Cloning the IL-24 / MDA-7 gene into a replication-deficient adenovirus to construct the expression vector Ad-mda7 can induce the apoptosis of various tumor cells, but adenovirus as a vector has biological safety problems
And the research on the therapeutic effect of IL-24 on liver cancer and small intestine cancer has not been reported yet.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Configuration of cell facter IL-24 eucargon expression carrier and application
  • Configuration of cell facter IL-24 eucargon expression carrier and application
  • Configuration of cell facter IL-24 eucargon expression carrier and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0071] 1. Construction method of human IL-24 eukaryotic recombinant expression vector

[0072] 1.1 Amplification and purification of the target gene

[0073] Primer design and synthesis: primers were designed according to the human IL-24 GeneBank sequence (NM006850), upstream primer: 5'GC AGATCT AATTTTCAACAGAGGCTG-3', containing BglII restriction site; downstream primer: 5'CG GTC GAC TCAGAGCTTGTAGAATTTCTG-3', containing the Sal I restriction site. Primers were synthesized by Shanghai Boya Biotechnology Co., Ltd. Using the plasmid TRAPIL-24 inserted into the complete coding region of human IL-24 as a template, PCR amplification was carried out from the second amino acid encoded by the N-terminal of human IL-24 using the above primers. The reaction conditions for the amplification were: pre-denaturation at 95°C for 2 minutes, denaturation at 95°C for 36s, annealing at 56°C for 36s, extension at 72°C for 1 minute and 24s, amplification for 25 cycles, and extension at 72°C for...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A method for configuring the eucaryotic expression carrier of cell factor IL-24 includes designing the ascending and descending primers, PCR amplifying begining from the second amino acid in the code at human IL-24 N terminal by using TRAPIL-24 plasmid as template, cutting off target band, purifying it with reagent kit, configuring and determining recombinant plasmid pEGFP-CI-IL-24, respectively enzyme-severing the PCR product and carrier pEGFP by Bgl II and Sal I, purifying them by reagent kit, linking fragment, culturing, cloning, determining and sequencing. The recombinant cell factor Il-24 can be used to treat liver cancer, small intestine cancer and melanoma.

Description

technical field [0001] The invention belongs to the fields of molecular immunology and tumor immunology, and more specifically relates to a method for constructing a eukaryotic expression vector of cytokine IL-24, and also relates to the use of recombinant cytokine IL-24 expressed by it in the treatment of liver cancer, small intestine cancer and melanoma the use of. Background technique [0002] Interleukin-24 (Interleukin-24, IL-24) is a new cytokine just discovered and determined in 2002 (Caudell EG, Mumm JB, Poindexter N, Ekmekcioglu S, Mhashilar AM, Yang XH, Retter MW, Hill P , Chada S, Grimm EA.The protein product of the tumor suppressor gene, melanoma differentiation-associated gene7, exhibits immunostimulatory activity and is designated IL-24.J Immunol.2002,168(12):6041-6; Zhang Xiaolian, Wang Fubing, new Cytokine IL-24 and its prospect, Journal of Cellular and Molecular Immunology 2003, 19(5), S20-S22.). IL-24 belongs to the IL-10 cytokin...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K48/00A61P35/00C12N15/10C12N15/24C12N15/79
Inventor 章晓联瞿少刚周翔吴建国陈明李平飞
Owner WUHAN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com